Article Details

Rivus' trial of HU6 meets primary and secondary endpoints

Retrieved on: 2024-08-14 20:20:34

Tags for this article:

Click the tags to see associated articles and topics

Rivus' trial of HU6 meets primary and secondary endpoints. View article details on hiswai:

Excerpt

The gold standard of business intelligence. Find out more. The randomised, double-blind, placebo-controlled, parallel-group, dose-escalation trial ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo